The U.S. Food and Drug Administration’s database indicates that the abbreviated new drug application (ANDA) 087157 for the product FLUONID has a marketing status of "Discontinued." FLUONID is a topical ointment containing 0.025% fluocinonide. The product is not designated as a reference drug and does not have a reference standard. The sponsor listed for this ANDA is Allergan Herbert. No further details on the reason for discontinuation are provided in the FDA entry.
Regulatorische Updates5. Sept. 2026•1 Min. Lesezeit
FDA Discontinues FLUONID Topical Ointment (ANDA 087157)
The FDA lists the FLUONID ointment (0.025% fluocinonide) under ANDA 087157 as discontinued, sponsored by Allergan Herbert.
Zusammengestellt vom PharmaCountry-Team · Quelle: FDA.gov
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen